Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children.

COVID-19 Kawasaki disease MIS-C PIMS-TS SARS-CoV-2 case report cytokine

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2021
Historique:
received: 29 04 2021
accepted: 21 06 2021
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 10 8 2021
Statut: epublish

Résumé

Multisystem inflammatory syndrome in children (MIS-C) is a severe disease that is reportedly linked to coronavirus disease 2019. Affected patients present with gastrointestinal symptoms and cardiovascular dysfunction, in addition to Kawasaki disease-like features, suggesting the potential for overlapping disease mechanisms. Kawasaki disease has been reported among individuals of East Asian ethnicities, whereas there is minimal clinical literature regarding the occurrence of MIS-C among individuals of Asian ethnicities. A few reports thus far have described changes in cytokine kinetics during the course of disease in patients with MIS-C. We followed the temporal cytokine kinetics in a 9-year-old Japanese girl who exhibited a classical trajectory of MIS-C. The patient exhibited right cervical swelling and pain, abdominal pain, vomiting, and lip reddening, which developed 31 days after she was diagnosed with severe acute respiratory syndrome coronavirus-2 infection. The patient was diagnosed with Kawasaki disease on her fifth day of illness; because she fulfilled the criteria for MIS-C, she was also diagnosed with this disease on her fifth day of illness. Her fever rapidly resolved upon administration of intravenous immunoglobulin, aspirin, and prednisolone. On the patient's sixth day of illness, she developed acute myocarditis, which was treated with two diuretics and one vasodilator; the myocarditis ameliorated within a few days. Analyses of temporal kinetics for 71 serum cytokines revealed several patterns of cytokine changes that were consistent with the patient's clinical course of disease. Importantly, there was a clear distinction between cytokines that did and did not decrease rapidly following post-treatment fever resolution. These findings may be useful for the assessment of disease status and selection of therapy in patients with similar symptoms; they may also provide insights for basic and clinical research regarding MIS-C.

Identifiants

pubmed: 34368030
doi: 10.3389/fped.2021.702318
pmc: PMC8335158
doi:

Types de publication

Case Reports

Langues

eng

Pagination

702318

Informations de copyright

Copyright © 2021 Takasago, Sakai, Sugiyama, Mizokami, Hamada, Ishizaka, Miyoshi-Akiyama, Matsunaga, Ueno, Shichino and Mizukami.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mediterr J Rheumatol. 2020 Sep 21;31(Suppl 2):268-274
pubmed: 33196004
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Emerg Infect Dis. 2021 Apr;27(4):1196-1200
pubmed: 33539720
Circulation. 2006 Jun 6;113(22):2606-12
pubmed: 16735679
Front Pediatr. 2021 Mar 19;9:625456
pubmed: 33816399
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Transl Pediatr. 2021 Jan;10(1):121-135
pubmed: 33633944
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
Front Pediatr. 2020 Nov 30;8:576912
pubmed: 33330276
Front Pharmacol. 2017 Mar 28;8:163
pubmed: 28400731
Pediatr Int. 2020 Oct;62(10):1135-1138
pubmed: 33001522
Front Pediatr. 2021 Jan 05;8:594127
pubmed: 33469522
Lancet. 2012 Apr 28;379(9826):1613-20
pubmed: 22405251
Indian J Pediatr. 2020 Sep;87(9):745-747
pubmed: 32462354
Cell. 2020 Nov 12;183(4):982-995.e14
pubmed: 32991843
Front Immunol. 2021 Mar 26;12:654587
pubmed: 33841438
J Clin Invest. 2020 Nov 2;130(11):5942-5950
pubmed: 32701511
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33497356
Euro Surveill. 2020 Jun;25(22):
pubmed: 32524957
BMJ. 2020 Jun 3;369:m2094
pubmed: 32493739
Clin Exp Pediatr. 2021 Feb;64(2):68-75
pubmed: 33445833
Nat Genet. 2008 Jan;40(1):35-42
pubmed: 18084290
J Pediatr. 2020 Oct;225:23-29.e2
pubmed: 32454114

Auteurs

Satoshi Takasago (S)

Department of Pediatrics, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Aiko Sakai (A)

Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Masaya Sugiyama (M)

Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Masashi Mizokami (M)

Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Hiromichi Hamada (H)

Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.

Yukihito Ishizaka (Y)

Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Tohru Miyoshi-Akiyama (T)

Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Akihiro Matsunaga (A)

Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Mikako Ueno (M)

Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Hiroyuki Shichino (H)

Department of Pediatrics, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Ayumi Mizukami (A)

Department of Pediatrics, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Classifications MeSH